Controling the cytoskeleton during CEACAM3-mediated phagocytosis

dc.contributor.authorKuiper, Johannes W. P.
dc.contributor.authorGregg, Helena
dc.contributor.authorSchüber, Meike
dc.contributor.authorKlein, Jule
dc.contributor.authorHauck, Christof R.
dc.date.accessioned2024-02-16T08:10:37Z
dc.date.available2024-02-16T08:10:37Z
dc.date.issued2024
dc.description.abstractPhagocytosis, an innate defense mechanism of multicellular animals, is initiated by specialized surface receptors. A phagocytic receptor expressed by human polymorphonuclear granulocytes, the major professional phagocytes in our body, is one of the fastest evolving human proteins implying a special role in human biology. This receptor, CEACAM3, is a member of the CarcinoEmbryonic Antigen-related Cell Adhesion Molecule (CEACAM) family and dedicated to the immediate recognition and rapid internalization of human-restricted pathogens. In this focused contribution, we will review the special adaptations of this protein, which co-evolves with different species of mucosa-colonizing bacteria. While the extracellular Immunoglobulin-variable (IgV)-like domain recognizes various bacterial adhesins, an Immunoreceptor Tyrosine-based Activation Motif (ITAM)-like sequence in the cytoplasmic tail of CEACAM3 constitutes the central signaling hub to trigger actin rearrangements needed for efficient phagocytosis. A major emphasis of this review will be placed on recent findings, which have revealed the multi-level control of this powerful phagocytic device. As tyrosine phosphorylation and small GTPase activity are central for CEACAM3-mediated phagocytosis, the counterregulation of CEACAM3 activity involves the receptor-type protein tyrosine phosphatase J (PTPRJ) as well as the Rac-GTP scavenging protein Cyri-B. Interference with such negative regulatory circuits has revealed that CEACAM3-mediated phagocytosis can be strongly enhanced. In principle, the knowledge gained by studying CEACAM3 can be applied to other phagocytic systems and opens the door to treatments, which boost the phagocytic capacity of professional phagocytes.
dc.description.versionpublisheddeu
dc.identifier.doi10.1016/j.ejcb.2024.151384
dc.identifier.ppn1880914344
dc.identifier.urihttps://kops.uni-konstanz.de/handle/123456789/69357
dc.language.isoeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCEA-related cell adhesion molecule
dc.subjectImmunoreceptor tyrosine-based activation motif
dc.subjectPhagocytosis
dc.subjectTyrosine phosphorylation
dc.subjectRac
dc.subjectPathogenic bacteria
dc.subject.ddc570
dc.titleControling the cytoskeleton during CEACAM3-mediated phagocytosiseng
dc.typeJOURNAL_ARTICLE
dspace.entity.typePublication
kops.citation.bibtex
@article{Kuiper2024Contr-69357,
  year={2024},
  doi={10.1016/j.ejcb.2024.151384},
  title={Controling the cytoskeleton during CEACAM3-mediated phagocytosis},
  number={1},
  volume={103},
  issn={0171-9335},
  journal={European Journal of Cell Biology},
  author={Kuiper, Johannes W. P. and Gregg, Helena and Schüber, Meike and Klein, Jule and Hauck, Christof R.},
  note={Article Number: 151384}
}
kops.citation.iso690KUIPER, Johannes W. P., Helena GREGG, Meike SCHÜBER, Jule KLEIN, Christof R. HAUCK, 2024. Controling the cytoskeleton during CEACAM3-mediated phagocytosis. In: European Journal of Cell Biology. Elsevier. 2024, 103(1), 151384. ISSN 0171-9335. eISSN 1618-1298. Available under: doi: 10.1016/j.ejcb.2024.151384deu
kops.citation.iso690KUIPER, Johannes W. P., Helena GREGG, Meike SCHÜBER, Jule KLEIN, Christof R. HAUCK, 2024. Controling the cytoskeleton during CEACAM3-mediated phagocytosis. In: European Journal of Cell Biology. Elsevier. 2024, 103(1), 151384. ISSN 0171-9335. eISSN 1618-1298. Available under: doi: 10.1016/j.ejcb.2024.151384eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/69357">
    <dcterms:issued>2024</dcterms:issued>
    <dc:creator>Hauck, Christof R.</dc:creator>
    <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:language>eng</dc:language>
    <dc:creator>Gregg, Helena</dc:creator>
    <dcterms:title>Controling the cytoskeleton during CEACAM3-mediated phagocytosis</dcterms:title>
    <dc:creator>Kuiper, Johannes W. P.</dc:creator>
    <dc:contributor>Kuiper, Johannes W. P.</dc:contributor>
    <dc:contributor>Gregg, Helena</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2024-02-16T08:10:37Z</dc:date>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Hauck, Christof R.</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2024-02-16T08:10:37Z</dcterms:available>
    <dc:contributor>Klein, Jule</dc:contributor>
    <dc:creator>Klein, Jule</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/69357/1/Kuiper_2-y936m86p30o15.pdf"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/69357/1/Kuiper_2-y936m86p30o15.pdf"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
    <dcterms:abstract>Phagocytosis, an innate defense mechanism of multicellular animals, is initiated by specialized surface receptors. A phagocytic receptor expressed by human polymorphonuclear granulocytes, the major professional phagocytes in our body, is one of the fastest evolving human proteins implying a special role in human biology. This receptor, CEACAM3, is a member of the CarcinoEmbryonic Antigen-related Cell Adhesion Molecule (CEACAM) family and dedicated to the immediate recognition and rapid internalization of human-restricted pathogens. In this focused contribution, we will review the special adaptations of this protein, which co-evolves with different species of mucosa-colonizing bacteria. While the extracellular Immunoglobulin-variable (Ig&lt;sub&gt;V&lt;/sub&gt;)-like domain recognizes various bacterial adhesins, an Immunoreceptor Tyrosine-based Activation Motif (ITAM)-like sequence in the cytoplasmic tail of CEACAM3 constitutes the central signaling hub to trigger actin rearrangements needed for efficient phagocytosis. A major emphasis of this review will be placed on recent findings, which have revealed the multi-level control of this powerful phagocytic device. As tyrosine phosphorylation and small GTPase activity are central for CEACAM3-mediated phagocytosis, the counterregulation of CEACAM3 activity involves the receptor-type protein tyrosine phosphatase J (PTPRJ) as well as the Rac-GTP scavenging protein Cyri-B. Interference with such negative regulatory circuits has revealed that CEACAM3-mediated phagocytosis can be strongly enhanced. In principle, the knowledge gained by studying CEACAM3 can be applied to other phagocytic systems and opens the door to treatments, which boost the phagocytic capacity of professional phagocytes.</dcterms:abstract>
    <dc:contributor>Schüber, Meike</dc:contributor>
    <dc:creator>Schüber, Meike</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/69357"/>
  </rdf:Description>
</rdf:RDF>
kops.description.funding{"first": "dfg", "second": "HA 2856/10-1"}
kops.description.funding{"first": "dfg", "second": "HA 2856/11-1"}
kops.description.openAccessopenaccessgold
kops.flag.isPeerReviewedtrue
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-2-y936m86p30o15
kops.sourcefieldEuropean Journal of Cell Biology. Elsevier. 2024, <b>103</b>(1), 151384. ISSN 0171-9335. eISSN 1618-1298. Available under: doi: 10.1016/j.ejcb.2024.151384deu
kops.sourcefield.plainEuropean Journal of Cell Biology. Elsevier. 2024, 103(1), 151384. ISSN 0171-9335. eISSN 1618-1298. Available under: doi: 10.1016/j.ejcb.2024.151384deu
kops.sourcefield.plainEuropean Journal of Cell Biology. Elsevier. 2024, 103(1), 151384. ISSN 0171-9335. eISSN 1618-1298. Available under: doi: 10.1016/j.ejcb.2024.151384eng
relation.isAuthorOfPublicationf3bc222a-bcad-49c2-9cac-647ab980845d
relation.isAuthorOfPublication54b4698d-faaf-43ad-836b-c3951bc7611f
relation.isAuthorOfPublicationeb6abcac-6497-4c0c-abf8-505c67a97d9c
relation.isAuthorOfPublicationd7d3e9d2-6d62-44db-833a-1f0b7e12b593
relation.isAuthorOfPublication10b5a6e0-b3c3-41a0-82c2-09e5d73b14ea
relation.isAuthorOfPublication.latestForDiscoveryf3bc222a-bcad-49c2-9cac-647ab980845d
source.bibliographicInfo.articleNumber151384
source.bibliographicInfo.issue1
source.bibliographicInfo.volume103
source.identifier.eissn1618-1298
source.identifier.issn0171-9335
source.periodicalTitleEuropean Journal of Cell Biology
source.publisherElsevier

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
Kuiper_2-y936m86p30o15.pdf
Größe:
3.72 MB
Format:
Adobe Portable Document Format
Kuiper_2-y936m86p30o15.pdf
Kuiper_2-y936m86p30o15.pdfGröße: 3.72 MBDownloads: 87

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
3.96 KB
Format:
Item-specific license agreed upon to submission
Beschreibung:
license.txt
license.txtGröße: 3.96 KBDownloads: 0